Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study
Authors:
- Sandro ArdizzoneSASandro Ardizzone
- Giovanni LombardiGLGiovanni Lombardi
- Generoso UomoGUGeneroso Uomo
- Oreste PieramicoOPOreste Pieramico
- Gabriele Bianchi PorroGPGabriele Bianchi Porro
- 1 June 2007
- journal article
- research article
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 65 (7) , 982-987
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: A 6-year survey and cost-effectiveness analysisDigestive and Liver Disease, 2006
- Prevention of post-ERCP pancreatitis: a comprehensive reviewGastrointestinal Endoscopy, 2004
- Comparison of Two Dosing Regimens of Gabexate in The Prophylaxis of Post-Ercp PancreatitisAmerican Journal of Gastroenterology, 2003
- Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: A multicenter, placebo-controlled, randomized clinical trialGastrointestinal Endoscopy, 2002
- Complications of Diagnostic and Therapeutic Ercp: A Prospective Multicenter StudyAmerican Journal of Gastroenterology, 2001
- Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysisGastrointestinal Endoscopy, 2000
- Pathophysiology of PancreatitisDigestion, 1999
- Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter studyGastrointestinal Endoscopy, 1998
- Gabexate for the Prevention of Pancreatic Damage Related to Endoscopic Retrograde CholangiopancreatographyNew England Journal of Medicine, 1996
- Endoscopic sphincterotomy complications and their management: an attempt at consensusGastrointestinal Endoscopy, 1991